Stockscreener 앱 받기
4.24
19.44%
0.69
시간 외 거래:
4.23
-0.010
-0.24%
전일 마감가:
$3.55
열려 있는:
$3.82
하루 거래량:
274.95K
Relative Volume:
1.74
시가총액:
$219.19M
수익:
$81.06M
순이익/손실:
$-55.55M
주가수익비율:
-3.7193
EPS:
-1.14
순현금흐름:
$-47.98M
1주 성능:
+29.66%
1개월 성능:
+19.61%
6개월 성능:
+53.07%
1년 성능:
-27.27%
1일 변동 폭
$3.81
$4.27
1주일 범위
$3.275
$4.27
52주 변동 폭
$2.03
$7.05
Sight Sciences Inc Stock (SGHT) Company Profile
명칭
Sight Sciences Inc
전화
(415) 889-0550
주소
4040 CAMPBELL AVE,, MENLO PARK
SGHT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
4.24 | 190.26M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-11-04 | 다운그레이드 | Lake Street | Buy → Hold |
| 2024-08-21 | 개시 | Lake Street | Buy |
| 2023-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-04 | 개시 | Needham | Hold |
| 2022-07-26 | 개시 | Stifel | Hold |
| 2022-02-03 | 개시 | William Blair | Outperform |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Sight Sciences Inc 주식(SGHT)의 최신 뉴스
Risk adjusted return profile for Sight Sciences Inc. analyzedPrice Action Trading with Volume Confirmation - Newser
Sight Sciences, Inc. (NASDAQ:SGHT) Q2 2025 Earnings Call Transcript - MSN
Sight Sciences raises 2025 revenue guidance to $72M–$76M amid strong OMNI growth and strategic focus on MIGS leadership - MSN
Does Sight Sciences (NASDAQ:SGHT) Have A Healthy Balance Sheet? - simplywall.st
A Quick Look at Today's Ratings for Sight Sciences(SGHT.US), With a Forecast Between $4 to $5 - 富途牛牛
Sight Sciences Reports Q2 EPS, Revenue Above Consensus, Glaucoma Ordering Accounts Reach New High - AInvest
Sight Sciences stock rating upgraded by Lake Street on stabilizing business - Investing.com Australia
Sight Sciences' Q2 2025: Navigating Contradictions in TearCare Reimbursement and Market Dynamics - AInvest
Sight Sciences Boosts 2025 Revenue Guidance to $72M-$76M on OMNI Growth and MIGS Leadership Focus - AInvest
Earnings call transcript: Sight Sciences Q2 2025 beats revenue expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Sight Sciences Q2 2025 beats revenue expectations - Investing.com
Sight Sciences August 2025 slides: Targeting growth in $9B eye care market despite Q1 headwinds - Investing.com Australia
Sight Sciences 2025 Q2 Earnings Slight Improvement in Losses Amid Revenue Decline - AInvest
Sight Sciences Reports Q2 2025 Financial Results - TipRanks
Sight Sciences Lifts Outlook Despite Revenue Slump - Finimize
Sight Sciences Releases Second Quarter Results and Raises Full-Year Guidance - VisionMonday.com
Sight Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Sight Sciences, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Sight Sciences reports Q2 EPS (23c), consensus (28c) - TipRanks
Sight Sciences: Navigating Revenue Headwinds and Regulatory Challenges to Secure Long-Term Growth - AInvest
Sight Sciences: A Resilient Earnings Beat Signals Undervaluation and Growth in Ophthalmic Innovation - AInvest
Sight Sciences Raises Full-Year Revenue Guidance - TipRanks
Sight Sciences earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance - GlobeNewswire
Sight Sciences Q2 Earnings: Revenue Falls 8%, But Company Raises Full Year Outlook on Strong Glaucoma Growth - Stock Titan
SAHARA trial demonstrates sustained TearCare benefits for evaporative DED - Ophthalmology Times
Sight Sciences releases cost-utility analysis comparing TearCare and cyclosporine 0.05% in dry eye - Optometry Times
Strategies to average down on Sight Sciences Inc.Day Trading Setup Forecast with Trend Model - Newser
Will Sight Sciences Inc. see short term momentumPortfolio Positioning Strategy With Timing - Newser
Will Sight Sciences Inc. price bounce be sustainableDaily Profit Watch With Forecast Confidence - Newser
Sight Sciences (SGHT) to Release Quarterly Earnings on Thursday - Defense World
What high frequency data says about Sight Sciences Inc.Equity Signal Recap With Long-Term Summary - Newser
What makes Sight Sciences Inc. stock price move sharplyFree Fundamental Growth Stock Analysis - Newser
Will Sight Sciences Inc. outperform the marketFree Community Verified Stock Suggestions - Newser
Is Sight Sciences Inc. Stock a Good Fit for Conservative InvestorsConsistent Gain Plan with AI Support - Newser
Is Sight Sciences Inc. a good long term investmentInvest smarter with expert stock recommendations - Jammu Links News
What are analysts’ price targets for Sight Sciences Inc. in the next 12 monthsGet daily expert analysis for smarter investing - Jammu Links News
What is Sight Sciences Inc. company’s growth strategyAccelerated investment success - Jammu Links News
Is it the right time to buy Sight Sciences Inc. stockInvest in stocks with strong fundamentals - Jammu Links News
When is Sight Sciences Inc. stock expected to show significant growthFree Predictions - Jammu Links News
How Sight Sciences Inc. stock performs during market volatilityEquity Market Return Forecast Model Update - Newser
Historical volatility pattern of Sight Sciences Inc. visualizedRisk-Managed Trade Alerts for Consistency - Newser
Should I hold or sell Sight Sciences Inc. stock in 2025High-octane investment opportunities await - Jammu Links News
What institutional investors are buying Sight Sciences Inc. stockCapitalize on market momentum for maximum gains - Jammu Links News
How volatile is Sight Sciences Inc. stock compared to the marketBuild wealth faster with high-performing stocks - Jammu Links News
What is the dividend policy of Sight Sciences Inc. stockFree Stock Market Trend Analysis - Jammu Links News
Sight Sciences Inc. Stock Analysis and ForecastTriple returns potential - Jammu Links News
Sight Sciences Inc (SGHT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):